Pilot Study Enhancing Telemedicine Care Delivery for Adults With Complex Type 2 Diabetes
Sponsor: University of Pittsburgh
Trial Details
| Condition | Type 2 Diabetes |
| Intervention | Enhanced Telemedicine for Type 2 Diabetes; Usual Telemedicine Endocrinology Care for T2D |
| Phase | NA |
| Status | Active |
| Participants | 50 |
| Est. Completion | 1 Oct 2026 |
| Last Updated | 5 June 2026 |
Primary Outcome
Recruitment percentage; Loss to follow up
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * adults 18 years or older * Diagnosis of type 2 diabetes based on abbreviated ICD-10 code E11.X in medical record or self-report * HbA1c greater than or equal to 8% based on most recent value at time of recruitment * Patients must own or have access to a smart phone, tablet, or home computer with data or internet connection that allows access to video-based visits * Patient must use insulin * Patients must have \>2 comorbid chronic health conditions * Be able to provide informed consent * Reside in Pennsylvania Exclusion criteria: * Age over 80 based on date of birth in electronic medical record * Visit with an endocrinologist in the prior 1 years * Dementia, ESRD, malignancy based on abbreviated ICD-10 codes below in medical record or self-report of associated condition * Dementia: A81.0x, F01.5x, F02.8x, F03.9x, F10.27, F10.97, F13.27, F13.97, F18.97, F19.17, F19.27, F19.97, G30.x, G31.0x, G31.1, G31.83, G31.85 * Malignancy, except non-melanoma skin cancer: C00.x-C14.x, C15.x-C26.x, C3x.xx, C40.xx-C41.x, C43.x, C4A.xx, C45.x-C49.xx, C50.xxx, C51.x-C58, C60.x-C63.x, C64.x- C68.x, C69.xx-C72.x, C73-C76.x, C7A.xx, C80.xx-C96.x (except C90.x1, C91.x1, C92.x1, C93.x1, C94.x1, C95.x1) * ESRD N18.6 * Type 1, gestational, or other diabetes based on abbreviated ICD-10 codes below in medical record or self-report of associated condition * Type 1 diabetes: E10.X * Gestational diabetes: O24.X, E08.X * Other diabetes: E09.X, E13.2 * Pregnant or planning to become pregnant in next 6 months * Currently enrolled in another diabetes management intervention study
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service